Characterization of neural crest gene expression using a new transgenic Xenopus m

使用新的转基因非洲爪蟾来表征神经嵴基因表达

基本信息

  • 批准号:
    8526449
  • 负责人:
  • 金额:
    $ 10.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-08 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Craniofacial morphogenesis is a complicated developmental process that is controlled by many genes. In vertebrates, the majority of craniofacial structures are derived from the cranial neural crest (CNC), and abnormalities in CNC development often lead to craniofacial disorders. Such disorders are common in humans, with an occurrence rate of one per 700 newborns and hundreds of different syndromes reported to date. The long-term objective of this proposed research is to understand the molecular bases of CNC development and craniofacial disorders. Toward this objective a transgenic Xenopus tropicalis line that expresses fluorescent reporter in the neural crest lineage (the snail2-egfp line) has been generated for live imaging of CNC development. The goal of the current application is to test the application of this transgenic line in detecting CNC defects and purifyig CNC cells for molecular studies. The application has two specific aims. In the first aim, the snail2-egfp line will be further characterized and assessed for its usage in real-time detection of defects in early and late CNC development. The integration site of the transgene insertion will be mapped, and experiments will be carried out to determine if the transgene has any effect on CNC development or expression of nearby genes. To test if the transgenic line is suitable for real-time detection of aberrant CNC development, deficiencies in the CNC will be induced at different stages and monitored by using high- resolution fluorescence imaging. In the second aim, the snail2-egfp line will be used to isolate high-purity CNC cells for transcriptome analyses. Several methods, including fluorescence activated cell sorting, will be evaluated for their effectiveness in purifying EGFP-labeled CNC cells. Purified CNC cells collected at different developmental stages will be used for cDNA microarray studies to identify genes that are dynamically regulated in premigratory CNC cells. Genes of interest will be selected and their expression patterns will be validated by other molecular techniques; some of these genes will be further tested for their potential functions in CNC development in future studies. Thus the expected outcomes of the proposed research project include identification of new genes that are potentially important for CNC development, as well as establishment of a new methodology for direct detection of CNC defects in live embryos. The successful achievement of these outcomes will provide us new tools and knowledge in craniofacial research.
描述(申请人提供):颅面形态发生是一个复杂的发育过程,受许多基因控制。在脊椎动物中,大多数颅面结构源自颅神经嵴(CNC),CNC发育异常常常导致颅面疾病。此类疾病在人类中很常见,每 700 名新生儿中就有 1 人患有此类疾病,迄今为止已报告了数百种不同的综合症。这项研究的长期目标是了解 CNC 发育和颅面疾病的分子基础。为了实现这一目标,已经生成了在神经嵴谱系中表达荧光报告基因的转基因热带爪蟾品系(snail2-egfp品系),用于 CNC 发育的实时成像。当前应用的目标是测试该转基因系在检测 CNC 缺陷和纯化 CNC 细胞以进行分子研究方面的应用。该应用程序有两个具体目标。在第一个目标中,将进一步表征和评估 snail2-egfp 系列在实时检测中的用途 CNC 开发早期和后期的缺陷。将绘制转基因插入的整合位点,并进行实验以确定转基因是否对 CNC 发育或附近基因的表达有任何影响。为了测试转基因系是否适合实时检测异常的 CNC 发育,将在不同阶段诱导 CNC 的缺陷,并使用高分辨率荧光成像进行监测。在第二个目标中,snail2-egfp 系将用于分离高纯度 CNC 细胞以进行转录组分析。 将评估包括荧光激活细胞分选在内的多种方法在纯化 EGFP 标记的 CNC 细胞方面的有效性。在不同发育阶段收集的纯化 CNC 细胞将用于 cDNA 微阵列研究,以识别在迁移前 CNC 细胞中动态调节的基因。将选择感兴趣的基因,并通过其他分子技术验证其表达模式;在未来的研究中,将进一步测试其中一些基因在 CNC 开发中的潜在功能。因此,拟议研究项目的预期成果包括鉴定对 CNC 发育潜在重要的新基因,以及建立直接检测活胚胎 CNC 缺陷的新方法。这些成果的成功实现将为我们提供颅面研究的新工具和知识。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Evolution of Vertebrate Adam Genes; Duplication of Testicular Adams from Ancient Adam9/9-like Loci.
  • DOI:
    10.1371/journal.pone.0136281
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Bahudhanapati H;Bhattacharya S;Wei S
  • 通讯作者:
    Wei S
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shuo Wei其他文献

Shuo Wei的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shuo Wei', 18)}}的其他基金

Mechanisms of Neural Crest Induction and Craniofacial Disorders
神经嵴诱导和颅面疾病的机制
  • 批准号:
    10218138
  • 财政年份:
    2020
  • 资助金额:
    $ 10.66万
  • 项目类别:
Mechanisms of Neural Crest Induction and Craniofacial Disorders
神经嵴诱导和颅面疾病的机制
  • 批准号:
    10395572
  • 财政年份:
    2020
  • 资助金额:
    $ 10.66万
  • 项目类别:
Mechanisms of Neural Crest Induction and Craniofacial Disorders
神经嵴诱导和颅面疾病的机制
  • 批准号:
    10033926
  • 财政年份:
    2020
  • 资助金额:
    $ 10.66万
  • 项目类别:
Mechanisms of Neural Crest Induction and Craniofacial Disorders
神经嵴诱导和颅面疾病的机制
  • 批准号:
    10614427
  • 财政年份:
    2020
  • 资助金额:
    $ 10.66万
  • 项目类别:
A conserved ADAM-ephrin-Wnt signaling axis in neural crest development and cancer
神经嵴发育和癌症中保守的 ADAM-ephrin-Wnt 信号轴
  • 批准号:
    9316794
  • 财政年份:
    2015
  • 资助金额:
    $ 10.66万
  • 项目类别:
A conserved ADAM-ephrin-Wnt signaling axis in neural crest development and cancer
神经嵴发育和癌症中保守的 ADAM-ephrin-Wnt 信号轴
  • 批准号:
    9044804
  • 财政年份:
    2015
  • 资助金额:
    $ 10.66万
  • 项目类别:
Characterization of neural crest gene expression using a new transgenic Xenopus m
使用新的转基因非洲爪蟾来表征神经嵴基因表达
  • 批准号:
    8355269
  • 财政年份:
    2012
  • 资助金额:
    $ 10.66万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 10.66万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 10.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 10.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 10.66万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 10.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 10.66万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 10.66万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 10.66万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 10.66万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 10.66万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了